Connection
Robert Hoyer to Antibodies, Bispecific
This is a "connection" page, showing publications Robert Hoyer has written about Antibodies, Bispecific.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.226 |
|
|
|
-
Day D, Ganju V, Chung K, Si L, Mao L, Aghmesheh M, Hoyer R, Brewin K, Zeng S, Zhang M, Lu Q, Jiang C, Ren F, Zhu Y, Guo J. First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors. Br J Cancer. 2025 Jun; 132(10):905-912.
Score: 0.226